Gore’s Excluder iliac branch endoprosthesis, the first complete, fully engineered system (Gore designed iliac branch and internal iliac components) intended for endovascular treatment of common iliac artery aneurysms or aortoiliac aneurysms, has been included on the Australian Register of Therapeutic Goods.
The first patient procedures in Australia were successfully completed by vascular surgeons Steven Dubenec, head of Department of Vascular Surgery at Royal Prince Alfred Hospital, Sydney, and Jack Loa, at Macquarie University Hospital, Sydney.
This new device—used in conjunction with Gore Excluder abdominal aortic aneurysm endoprosthesis components to isolate the common iliac artery from systemic blood flow and preserve blood flow in the external iliac and internal iliac arteries—is built on Gore’s technology platform and designed using the same durable, expanded polytetrafluoroethylene (ePTFE) graft.
“Based on the design of the Excluder device, this system provides a wide treatment range and long-term durability, which is extremely important for optimal clinical success,” said Dubenec. “The pre-cannulated branch and bi-femoral delivery elements of the Excluder support the ease of use of this device.”
The system provides a treatment range of 6.5–13.5mm for the internal iliac arteries, and a treatment range of 6.5–25mm for the external iliac arteries. The delivery profile of the loaded catheter allows the use of a 16Fr introducer sheath for the iliac branch component, and a 12Fr flexible, reinforced introducer sheath for the internal iliac component.
“This new, fully engineered system builds off the trusted performance of the Excluder abdominal aortic aneurysm endoprosthesis, providing physicians with a minimally invasive treatment option for iliac repair,” said Ryan Takeuchi, Gore aortic business leader.
